In her career, she has driven corporate growth and revenue from concept through commercialization with global industry leaders such as BASF, Roche, DSM, Glanbia and OmniActive.
"I've seen the industry transition from a fringe industry in parts of it to really becoming more mainstream and really focused and professional," Doyle said. "I love seeing this happen. I think where the evolution has gone first if we look at the quality. We're seeing an overall uptick in quality, and the bar gets raised every year since I've been here."
She added that from the ingredients side, there are a growing number of technological advances and science-backed branded ingredients that help manufacturers bring new products to market.
"I think where we are falling a little short is the fact that the science is mostly on men, or largely has been on men, and then we can't really focus that data on women," she said.
"I think it's important for manufacturers to look at that science and start thinking about how to bring more women into the cohorts, and bring more women into research. I think these are some of the areas that we can still see additional evolution from that side. But we've really come far, and it's great to see the opportunities that the industry has brought to consumers in terms of bringing them health and wellness."
Doyle is a founding member and secretary of Women in Nutraceuticals (WIN) and currently volunteers as a mentor and selection committee member for the Nutrition Capital Network (NCN). She also serves on the Regulatory Affairs, Consumer Survey Advisory and Communications and Media Outreach committees of the Council for Responsible Nutrition (CRN).
